Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within.

Kajani S, Curley S, McGillicuddy FC.

Int J Mol Sci. 2018 Jul 6;19(7). pii: E1971. doi: 10.3390/ijms19071971. Review.

2.

Ultrasound Doppler as an Imaging Modality for Selection of Murine 4T1 Breast Tumors for Combination Radiofrequency Hyperthermia and Chemotherapy.

Krzykawska-Serda M, Ho JC, Ware MJ, Law JJ, Newton JM, Nguyen L, Agha M, Curley SA, Corr SJ.

Transl Oncol. 2018 May 12;11(4):864-872. doi: 10.1016/j.tranon.2018.04.010. [Epub ahead of print]

3.

MRI compatible MS2 nanoparticles designed to cross the blood-brain-barrier: providing a path towards tinnitus treatment.

Apawu AK, Curley SM, Dixon AR, Hali M, Sinan M, Braun RD, Castracane J, Cacace AT, Bergkvist M, Holt AG.

Nanomedicine. 2018 Apr 14;14(7):1999-2008. doi: 10.1016/j.nano.2018.04.003. [Epub ahead of print]

PMID:
29665440
4.

Chemotherapy and Radiofrequency-Induced Mild Hyperthermia Combined Treatment of Orthotopic Pancreatic Ductal Adenocarcinoma Xenografts.

Krzykawska-Serda M, Agha MS, Ho JC, Ware MJ, Law JJ, Newton JM, Nguyen L, Curley SA, Corr SJ.

Transl Oncol. 2018 Jun;11(3):664-671. doi: 10.1016/j.tranon.2018.02.023. Epub 2018 Apr 3.

5.

Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response.

Newton JM, Flores-Arredondo JH, Suki S, Ware MJ, Krzykawska-Serda M, Agha M, Law JJ, Sikora AG, Curley SA, Corr SJ.

Sci Rep. 2018 Feb 22;8(1):3474. doi: 10.1038/s41598-018-21719-w.

6.

Biotransport kinetics and intratumoral biodistribution of malonodiserinolamide-derivatized [60]fullerene in a murine model of breast adenocarcinoma.

Lapin NA, Vergara LA, Mackeyev Y, Newton JM, Dilliard SA, Wilson LJ, Curley SA, Serda RE.

Int J Nanomedicine. 2017 Nov 15;12:8289-8307. doi: 10.2147/IJN.S138641. eCollection 2017.

7.

From basics to clinic: Cancer Nanotechnology.

Currell F, Curley S, Krpetić Ž, Bellringer M.

Cancer Nanotechnol. 2017;8(1):8. doi: 10.1186/s12645-017-0033-1. Epub 2017 Nov 10. No abstract available.

8.

Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.

Bruen R, Curley S, Kajani S, Crean D, O'Reilly ME, Lucitt MB, Godson CG, McGillicuddy FC, Belton O.

Cardiovasc Diabetol. 2017 Nov 6;16(1):143. doi: 10.1186/s12933-017-0626-3.

9.

A new mild hyperthermia device to treat vascular involvement in cancer surgery.

Ware MJ, Nguyen LP, Law JJ, Krzykawska-Serda M, Taylor KM, Cao HST, Anderson AO, Pulikkathara M, Newton JM, Ho JC, Hwang R, Rajapakshe K, Coarfa C, Huang S, Edwards D, Curley SA, Corr SJ.

Sci Rep. 2017 Sep 12;7(1):11299. doi: 10.1038/s41598-017-10508-6.

10.

The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.

Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN.

Cancer. 2018 Jan 1;124(1):74-83. doi: 10.1002/cncr.30968. Epub 2017 Aug 25.

PMID:
28841223
11.

Pancreatic adenocarcinoma response to chemotherapy enhanced with non-invasive radio frequency evaluated via an integrated experimental/computational approach.

Ware MJ, Curtis LT, Wu M, Ho JC, Corr SJ, Curley SA, Godin B, Frieboes HB.

Sci Rep. 2017 Jun 13;7(1):3437. doi: 10.1038/s41598-017-03040-0.

12.

The effects of non-invasive radiofrequency electric field hyperthermia on biotransport and biodistribution of fluorescent [60]fullerene derivative in a murine orthotopic model of breast adenocarcinoma.

Lapin NA, Krzykawska-Serda M, Dilliard S, Mackeyev Y, Serda M, Wilson LJ, Curley SA, Corr SJ.

J Control Release. 2017 Aug 28;260:92-99. doi: 10.1016/j.jconrel.2017.05.022. Epub 2017 May 17.

PMID:
28527736
13.

Non-Invasive Radiofrequency Field Treatment to Produce Hepatic Hyperthermia: Efficacy and Safety in Swine.

Ho JC, Nguyen L, Law JJ, Ware MJ, Keshishian V, Lara NC, Nguyen T, Curley SA, Corr SJ.

IEEE J Transl Eng Health Med. 2017 Apr 3;5:1500109. doi: 10.1109/JTEHM.2017.2672965. eCollection 2017.

14.

Optimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model.

Ware MJ, Krzykawska-Serda M, Chak-Shing Ho J, Newton J, Suki S, Law J, Nguyen L, Keshishian V, Serda M, Taylor K, Curley SA, Corr SJ.

Sci Rep. 2017 Mar 13;7:43961. doi: 10.1038/srep43961.

15.

The seven attributes of the academic surgeon: Critical aspects of the archetype and contributions to the surgical community.

Rosengart TK, Mason MC, LeMaire SA, Brandt ML, Coselli JS, Curley SA, Mattox KL, Mills JL, Sugarbaker DJ, Berger DA.

Am J Surg. 2017 Aug;214(2):165-179. doi: 10.1016/j.amjsurg.2017.02.003. Epub 2017 Feb 20.

16.

Unique heating curves generated by radiofrequency electric-field interactions with semi-aqueous solutions.

Lara NC, Haider AA, Wilson LJ, Curley SA, Corr SJ.

Appl Phys Lett. 2017 Jan 2;110(1):013701. doi: 10.1063/1.4973218. Epub 2017 Jan 4.

17.

Induction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors.

Bimonte S, Leongito M, Piccirillo M, Tamma ML, Vallifuoco M, Bracco A, Mancini A, Di Napoli D, Castaldo S, Cozzolino S, Iacobellis F, Grassi R, Granata V, Lastoria S, Curley S, Izzo F.

Infect Agent Cancer. 2016 Dec 1;11:62. doi: 10.1186/s13027-016-0103-8. eCollection 2016.

18.

The relationship between therapist-rated function and patient-reported outcome measures.

Braun Y, Mellema JJ, Peters RM, Curley S, Burchill G, Ring D.

J Hand Ther. 2017 Oct - Dec;30(4):516-521. doi: 10.1016/j.jht.2016.02.022. Epub 2016 Nov 29.

PMID:
27912920
19.

Water-structuring molecules and nanomaterials enhance radiofrequency heating in biologically relevant solutions.

Lara NC, Haider AA, Ho JC, Wilson LJ, Barron AR, Curley SA, Corr SJ.

Chem Commun (Camb). 2016 Oct 18;52(85):12630-12633.

20.

Generation of an in vitro 3D PDAC stroma rich spheroid model.

Ware MJ, Keshishian V, Law JJ, Ho JC, Favela CA, Rees P, Smith B, Mohammad S, Hwang RF, Rajapakshe K, Coarfa C, Huang S, Edwards DP, Corr SJ, Godin B, Curley SA.

Biomaterials. 2016 Nov;108:129-42. doi: 10.1016/j.biomaterials.2016.08.041. Epub 2016 Sep 2.

21.

Intravital microscopy for evaluating tumor perfusion of nanoparticles exposed to non-invasive radiofrequency electric fields.

Lapin NA, Krzykawska-Serda M, Ware MJ, Curley SA, Corr SJ.

Cancer Nanotechnol. 2016;7:5. Epub 2016 Jun 30.

22.

A recellularized human colon model identifies cancer driver genes.

Chen HJ, Wei Z, Sun J, Bhattacharya A, Savage DJ, Serda R, Mackeyev Y, Curley SA, Bu P, Wang L, Chen S, Cohen-Gould L, Huang E, Shen X, Lipkin SM, Copeland NG, Jenkins NA, Shuler ML.

Nat Biotechnol. 2016 Aug;34(8):845-51. doi: 10.1038/nbt.3586. Epub 2016 Jul 11.

23.

Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill.

Wang Z, Kerketta R, Chuang YL, Dogra P, Butner JD, Brocato TA, Day A, Xu R, Shen H, Simbawa E, Al-Fhaid AS, Mahmoud SR, Curley SA, Ferrari M, Koay EJ, Cristini V.

PLoS Comput Biol. 2016 Jun 10;12(6):e1004969. doi: 10.1371/journal.pcbi.1004969. eCollection 2016 Jun.

24.

Generation of Homogenous Three-Dimensional Pancreatic Cancer Cell Spheroids Using an Improved Hanging Drop Technique.

Ware MJ, Colbert K, Keshishian V, Ho J, Corr SJ, Curley SA, Godin B.

Tissue Eng Part C Methods. 2016 Apr;22(4):312-21. doi: 10.1089/ten.TEC.2015.0280. Epub 2016 Mar 9.

25.

Diagnosis and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma.

Ho J, Curley SA.

Cancer Treat Res. 2016;168:121-63. Review.

PMID:
29206368
26.

Decision processes and the slowing of simple choices in schizophrenia.

Heathcote A, Suraev A, Curley S, Gong Q, Love J, Michie PT.

J Abnorm Psychol. 2015 Nov;124(4):961-974. doi: 10.1037/abn0000117.

PMID:
26595475
27.

A New Imaging Platform for Visualizing Biological Effects of Non-Invasive Radiofrequency Electric-Field Cancer Hyperthermia.

Corr SJ, Shamsudeen S, Vergara LA, Ho JC, Ware MJ, Keshishian V, Yokoi K, Savage DJ, Meraz IM, Kaluarachchi W, Cisneros BT, Raoof M, Nguyen DT, Zhang Y, Wilson LJ, Summers H, Rees P, Curley SA, Serda RE.

PLoS One. 2015 Aug 26;10(8):e0136382. doi: 10.1371/journal.pone.0136382. eCollection 2015.

28.

Radiofrequency treatment alters cancer cell phenotype.

Ware MJ, Tinger S, Colbert KL, Corr SJ, Rees P, Koshkina N, Curley S, Summers HD, Godin B.

Sci Rep. 2015 Jul 13;5:12083. doi: 10.1038/srep12083.

29.

Gold nanoparticles stabilized with MPEG-grafted poly(l-lysine): in vitro and in vivo evaluation of a potential theranostic agent.

Bogdanov AA Jr, Gupta S, Koshkina N, Corr SJ, Zhang S, Curley SA, Han G.

Bioconjug Chem. 2015 Jan 21;26(1):39-50. doi: 10.1021/bc5005087. Epub 2014 Dec 11.

30.

CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.

Neve Polimeno M, Ierano C, D'Alterio C, Simona Losito N, Napolitano M, Portella L, Scognamiglio G, Tatangelo F, Maria Trotta A, Curley S, Costantini S, Liuzzi R, Izzo F, Scala S.

Cell Mol Immunol. 2015 Jul;12(4):474-82. doi: 10.1038/cmi.2014.102. Epub 2014 Nov 3.

31.

The effects of non-invasive radiofrequency treatment and hyperthermia on malignant and nonmalignant cells.

Curley SA, Palalon F, Sanders KE, Koshkina NV.

Int J Environ Res Public Health. 2014 Sep 3;11(9):9142-53. doi: 10.3390/ijerph110909142.

32.

Hyperthermia inhibits recombination repair of gemcitabine-stalled replication forks.

Raoof M, Zhu C, Cisneros BT, Liu H, Corr SJ, Wilson LJ, Curley SA.

J Natl Cancer Inst. 2014 Aug 15;106(8). pii: dju183. doi: 10.1093/jnci/dju183. Print 2014 Aug.

33.

Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells.

Curley SA, Palalon F, Lu X, Koshkina NV.

Cancer. 2014 Nov 1;120(21):3418-25. doi: 10.1002/cncr.28895. Epub 2014 Jul 1.

34.

Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.

Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia T, Conrad C, Curley SA, Vierling JM, Jalal P, Raghav K, Wallace M, Rashid A, Abbruzzese JL, Wolff RA, Morris JS.

J Natl Cancer Inst. 2014 May 9;106(5). pii: dju088. doi: 10.1093/jnci/dju088.

35.

Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma.

Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH.

Pract Radiat Oncol. 2013 Oct-Dec;3(4):344-8. doi: 10.1016/j.prro.2012.11.001. Epub 2012 Dec 8.

PMID:
24674408
36.

Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.

Raoof M, Corr SJ, Zhu C, Cisneros BT, Kaluarachchi WD, Phounsavath S, Wilson LJ, Curley SA.

Nanomedicine. 2014 Aug;10(6):1121-30. doi: 10.1016/j.nano.2014.03.004. Epub 2014 Mar 17.

37.

Molecular characterization of gallbladder cancer using somatic mutation profiling.

Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff RT, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I.

Hum Pathol. 2014 Apr;45(4):701-8. doi: 10.1016/j.humpath.2013.11.001. Epub 2013 Nov 12.

38.

Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment.

Koshkina NV, Briggs K, Palalon F, Curley SA.

Cancer. 2014 Feb 15;120(4):480-91. doi: 10.1002/cncr.28453. Epub 2013 Oct 25.

39.

Reassessing hepatocellular carcinoma staging in a changing patient population.

Kaseb AO, Shah NN, Hassabo HM, Morris JS, Xiao L, Abaza YM, Soliman K, Lee JS, Vauthey JN, Wallace M, Aloia TA, Curley S, Abbruzzese JL, Hassan MM.

Oncology. 2014;86(2):63-71. doi: 10.1159/000356573. Epub 2014 Jan 8.

40.

Cost-effectiveness of simultaneous resection and RFA versus 2-stage hepatectomy for bilobar colorectal liver metastases.

Abbott DE, Sohn VY, Hanseman D, Curley SA.

J Surg Oncol. 2014 May;109(6):516-20. doi: 10.1002/jso.23539. Epub 2013 Dec 23.

PMID:
24374772
41.

Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma.

Thomas RM, Aloia TA, Truty MJ, Tseng WH, Choi EA, Curley SA, Vauthey JN, Abdalla EK.

HPB (Oxford). 2014 Jul;16(7):677-85. doi: 10.1111/hpb.12202. Epub 2013 Dec 6.

42.

Morbidity and mortality in 1,174 patients undergoing hepatic parenchymal transection using a stapler device.

Raoof M, Aloia TA, Vauthey JN, Curley SA.

Ann Surg Oncol. 2014 Mar;21(3):995-1001. doi: 10.1245/s10434-013-3331-9. Epub 2013 Nov 19.

PMID:
24248530
43.

Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival.

Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Gupta S, Wallace MJ, Vauthey JN.

Br J Surg. 2013 Dec;100(13):1777-83. doi: 10.1002/bjs.9317.

44.

Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients.

Shindoh J, Tzeng CW, Aloia TA, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN.

J Gastrointest Surg. 2014 Jan;18(1):45-51. doi: 10.1007/s11605-013-2369-0. Epub 2013 Oct 16.

PMID:
24129824
45.

Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.

Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia T, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM.

Oncology. 2013;85(4):197-203. doi: 10.1159/000354698. Epub 2013 Sep 19.

46.

Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients.

Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA.

HPB (Oxford). 2014 May;16(5):459-68. doi: 10.1111/hpb.12155. Epub 2013 Aug 26.

47.
48.

RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.

Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM.

Ann Surg. 2013 Oct;258(4):619-26; discussion 626-7. doi: 10.1097/SLA.0b013e3182a5025a.

49.

Mechanistic patient-specific predictive correlation of tumor drug response with microenvironment and perfusion measurements.

Pascal J, Bearer EL, Wang Z, Koay EJ, Curley SA, Cristini V.

Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14266-71. doi: 10.1073/pnas.1300619110. Epub 2013 Aug 12.

50.

Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients.

Tzeng CW, Curley SA, Vauthey JN, Aloia TA.

HPB (Oxford). 2013 Oct;15(10):773-80. doi: 10.1111/hpb.12130. Epub 2013 Jul 22.

Supplemental Content

Loading ...
Support Center